Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.4B | 1.4B | 1.7B |
Cost of revenue | 981M | 1.0B | 1.1B | 1.1B |
Gross profit | 478M | 394M | 365M | 572M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 257M | 248M | 282M | 281M |
Other operating expenses | — | — | — | — |
Operating income | 64M | 2M | -88M | 138M |
Non operating interest income | ||||
Income | 10M | 17M | 14M | 16M |
Expense | 3M | 4M | 7M | 7M |
Other income expense | -3M | -58M | -27M | -4M |
Pretax income | 67M | -42M | -109M | 139M |
Tax provision | 25M | 19M | -26M | 34M |
Net income | 42M | -61M | -83M | 105M |
Basic EPS | 0.5 | — | -1.0 | 1.3 |
Diluted EPS | 0.5 | — | -1.0 | 1.2 |
Basic average shares | 79.7M | — | 80.3M | 81.2M |
Diluted average shares | 79.9M | — | 80.3M | 81.5M |
EBITDA | 211M | 159M | 65M | 286M |
Net income from continuing op. | 42M | -62M | -83M | 105M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |